PL3290405T3 - Sól kwasu mesylowego związku acylotiomocznika, jej kryształ oraz sposoby jej wytwarzania - Google Patents
Sól kwasu mesylowego związku acylotiomocznika, jej kryształ oraz sposoby jej wytwarzaniaInfo
- Publication number
- PL3290405T3 PL3290405T3 PL16786581T PL16786581T PL3290405T3 PL 3290405 T3 PL3290405 T3 PL 3290405T3 PL 16786581 T PL16786581 T PL 16786581T PL 16786581 T PL16786581 T PL 16786581T PL 3290405 T3 PL3290405 T3 PL 3290405T3
- Authority
- PL
- Poland
- Prior art keywords
- crystal
- acid salt
- production processes
- mesylic acid
- processes therefor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015092815 | 2015-04-30 | ||
| EP16786581.5A EP3290405B1 (en) | 2015-04-30 | 2016-04-28 | Mesylic acid salt of acylthiourea compound, crystal thereof, and production processes therefor |
| PCT/JP2016/063413 WO2016175305A1 (ja) | 2015-04-30 | 2016-04-28 | アシルチオウレア化合物のメシル酸塩及びその結晶並びにそれらの製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3290405T3 true PL3290405T3 (pl) | 2021-07-12 |
Family
ID=57199144
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16786581T PL3290405T3 (pl) | 2015-04-30 | 2016-04-28 | Sól kwasu mesylowego związku acylotiomocznika, jej kryształ oraz sposoby jej wytwarzania |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10143688B2 (pl) |
| EP (1) | EP3290405B1 (pl) |
| JP (1) | JP6676626B2 (pl) |
| CN (1) | CN107614489B (pl) |
| DK (1) | DK3290405T3 (pl) |
| ES (1) | ES2863586T3 (pl) |
| HK (1) | HK1247200A1 (pl) |
| HU (1) | HUE054405T2 (pl) |
| PL (1) | PL3290405T3 (pl) |
| PT (1) | PT3290405T (pl) |
| WO (1) | WO2016175305A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110312511B (zh) | 2017-02-15 | 2023-10-27 | 大鹏药品工业株式会社 | 医药组合物 |
| MA50251A (fr) | 2017-09-08 | 2021-06-02 | Taiho Pharmaceutical Co Ltd | Agent antitumoral et potentialisateur d'effet antitumoral |
| EP3854395A4 (en) | 2018-09-18 | 2022-06-15 | Taiho Pharmaceutical Co., Ltd. | COMBINATION THERAPY OF AN ACYLTHIOREA COMPOUND AND ABIRATERON |
| TW202140426A (zh) * | 2020-02-14 | 2021-11-01 | 日商大鵬藥品工業股份有限公司 | 醯基硫脲化合物的製造方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0911679B8 (pt) | 2008-04-10 | 2021-05-25 | Taiho Pharmaceutical Co Ltd | composto aciltioureia ou um sal do mesmo, uso do dito composto para tratar câncer, bem como agente farmacêutico, agente antitumoral e composição farmacêutica compreendendo dito composto |
| TWI594986B (zh) * | 2011-12-28 | 2017-08-11 | Taiho Pharmaceutical Co Ltd | Antineoplastic agent effect enhancer |
| US9149471B2 (en) | 2013-09-30 | 2015-10-06 | National University Corporation Tokyo University Of Agriculture And Technology | Therapeutic agent for osteoporosis |
-
2016
- 2016-04-28 HU HUE16786581A patent/HUE054405T2/hu unknown
- 2016-04-28 WO PCT/JP2016/063413 patent/WO2016175305A1/ja active Application Filing
- 2016-04-28 PL PL16786581T patent/PL3290405T3/pl unknown
- 2016-04-28 US US15/570,021 patent/US10143688B2/en active Active
- 2016-04-28 PT PT167865815T patent/PT3290405T/pt unknown
- 2016-04-28 EP EP16786581.5A patent/EP3290405B1/en active Active
- 2016-04-28 CN CN201680024210.1A patent/CN107614489B/zh active Active
- 2016-04-28 ES ES16786581T patent/ES2863586T3/es active Active
- 2016-04-28 DK DK16786581.5T patent/DK3290405T3/da active
- 2016-04-28 JP JP2017515618A patent/JP6676626B2/ja active Active
-
2018
- 2018-05-24 HK HK18106763.2A patent/HK1247200A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3290405A4 (en) | 2018-09-12 |
| HUE054405T2 (hu) | 2021-09-28 |
| JP6676626B2 (ja) | 2020-04-08 |
| US20180161317A1 (en) | 2018-06-14 |
| HK1247200A1 (zh) | 2018-09-21 |
| WO2016175305A1 (ja) | 2016-11-03 |
| EP3290405B1 (en) | 2021-02-17 |
| DK3290405T3 (da) | 2021-03-22 |
| ES2863586T3 (es) | 2021-10-11 |
| US10143688B2 (en) | 2018-12-04 |
| CN107614489B (zh) | 2021-05-11 |
| EP3290405A1 (en) | 2018-03-07 |
| CN107614489A (zh) | 2018-01-19 |
| JPWO2016175305A1 (ja) | 2018-04-12 |
| PT3290405T (pt) | 2021-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL262138A (en) | Cell-free production of ribonucleic acid | |
| HK1245762A1 (zh) | 丙烯酸生產方法 | |
| GB2550003B (en) | Process for the production of formaldehyde-stabilised urea | |
| IL249415A0 (en) | Electrolytic production of ammonia | |
| IL254413A0 (en) | Cell-free ribonucleic acid production | |
| HK1258002A1 (zh) | 羧基化的納米纖維素的生產 | |
| EP3315827A4 (en) | Process for production of gaskets | |
| HK1247200A1 (zh) | 酰基硫脲化合物的甲磺酸鹽及其晶體、以及它們的製造方法 | |
| EP3341405A4 (en) | PROCESS FOR INSULIN PRODUCTION | |
| GB201516516D0 (en) | Process of manufacture | |
| EP3414256A4 (en) | AMINO SALT OF OBETICHOLIC ACID | |
| HUP1700197A2 (en) | Industrial procedure for production of cariprazine | |
| PL3262023T3 (pl) | Sposób wytwarzania dienów | |
| GB201518792D0 (en) | Production of proteins | |
| ZA201701003B (en) | Process for the production of a pgm-enriched alloy | |
| FI20146056A (fi) | Menetelmä litiummetallifosfaattien tuottamiseksi | |
| DK3200779T3 (en) | Novel anthranilic acid derivatives | |
| ZA201801991B (en) | Process for the preparation of monochloroacetic acid | |
| ZA201800909B (en) | Process for the recovery of hydrochloric acid | |
| PL3271325T3 (pl) | Sposób wytwarzania (S)-metolachloru | |
| GB201416909D0 (en) | Method of forming concentrated solution | |
| GB2555726B (en) | Urea production method | |
| GB201700973D0 (en) | Process of manufacture | |
| PL3362424T3 (pl) | Wytwarzanie związków alkiloaromatycznych | |
| PT3271325T (pt) | Processo de produção de (s)-metolacloro |